Shinichiro Kawabe
- Biotechnology top 5%
- Cancer Research and Treatments 3
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 8
- Cancer-related Molecular Pathways 4
- Cancer Treatment and Pharmacology 4
- Genetics top 10%
- Virus-based gene therapy research 2
-
- Cell death mechanisms and regulation 3
- Cancer-related gene regulation 2
-
- Gastric Cancer Management and Outcomes 9
- Co-authors
- Jack A. RothRaymond E. MeynSunil ChadaAnupama MunshiHiroya TakiuchiKen‐ichi KatsuDebra Rose WilsonTomoyuki Saeki
- Cited by
- BiotechnologyOncologyGenetics
- Journals
- Oncogene (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Cancer Letters (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Shinichiro Kawabe
17 papers receiving 479 citations
Peers
Comparison fields: 5 of 56
- Biotechnology 100
- Oncology 271
- Genetics 186
- Immunology 71
- Molecular Biology 219
Countries citing papers authored by Shinichiro Kawabe
This map shows the geographic impact of Shinichiro Kawabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinichiro Kawabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinichiro Kawabe more than expected).
Fields of papers citing papers by Shinichiro Kawabe
This network shows the impact of papers produced by Shinichiro Kawabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinichiro Kawabe. The network helps show where Shinichiro Kawabe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shinichiro Kawabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 13 | |
| 2 | 2007 | 14 | |
| 3 | 2007 | 32 | |
| 4 | Thymidylate synthase gene expression in primary tumors predicts activity of s-1-based chemotherapy for advanced gastric cancer. | 2007 | 21 |
| 5 | [Weekly administration regimen of paclitaxel (PTX) in patient with inoperable or recurrent gastric cancer]. | 2006 | 3 |
| 6 | [S-1 combined with weekly paclitaxel in patients with advanced gastric cancer]. | 2006 | 2 |
| 7 | [Second-line chemotherapy in gastric cancer]. | 2005 | 8 |
| 8 | 2002 | 127 | |
| 9 | 2002 | 47 | |
| 10 | 2002 | 55 | |
| 11 | [Effectiveness of chemotherapy for outpatients with gastric or colorectal cancer]. | 2002 | 1 |
| 12 | 2002 | 46 | |
| 13 | 2001 | 41 | |
| 14 | 2000 | 35 | |
| 15 | 2000 | 25 | |
| 16 | 1999 | 9 | |
| 17 | 1999 | 9 | |
| 18 | [A case of recurrent advanced colon cancer treated with CPT-11 for second-line chemotherapy]. | 1997 | 1 |
About Shinichiro Kawabe
Shinichiro Kawabe is a scholar working on Oncology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 489 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer-related Molecular Pathways (4 papers), Cancer Treatment and Pharmacology (4 papers), Cell death mechanisms and regulation (3 papers), Cancer Research and Treatments (3 papers), Virus-based gene therapy research (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Biotechnology (100 citations), Oncology (271 citations) and Genetics (186 citations). Shinichiro Kawabe has collaborated with scholars based in Japan and United States. Frequent co-authors include Jack A. Roth, Raymond E. Meyn, Sunil Chada, Anupama Munshi, Hiroya Takiuchi, Ken‐ichi Katsu, Debra Rose Wilson, Tomoyuki Saeki, Louis A. Zumstein and Kerry Sieger. Their work appears in journals such as Oncogene, International Journal of Radiation Oncology*Biology*Physics and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.